NEW YORK , Sept. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit. ...

公司动态 - Gross Law Firm向Unicycive Therapeutics Inc (NASDAQ: UNCY)股东发布通知 [1]

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Unicycive Therapeutics, Inc. investors who were adversely affected by alleged securities fraud between March 29, 2024 and June 27, 2025. Follow the link below to get more information and be contacted by a member of our team: ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Unicycive Therapeutics, Inc. investors who were adversely affected by alleged securities fraud between March 29, 2024 and June 27, 2025. Follow the link below to get more information and b ...

NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 14, 2025. SO WHAT: If you purchased Unicycive securities dur ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY). Shareholders who purchased shares of UNCY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/unicycive-therapeutics-inc-loss- ...

NEW YORK, Sept. 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 14, 2025. SO WHAT: If you purchased Unicycive securities dur ...

诉讼背景 - Levi & Korsinsky律师事务所于2025年9月12日通知Unicycive Therapeutics Inc（NASDAQ: UNCY）投资者有关证券集体诉讼事宜 [1] - 该诉讼旨在为2024年3月29日至2025年6月27日期间因涉嫌证券欺诈而遭受损失的Unicycive Therapeutics Inc投资者挽回损失 [2] 指控内容 - 指控被告虚假陈述和/或隐瞒以下事实：Unicycive满足FDA生产合规要求的能力被夸大 [3] - 指控被告虚假陈述和/或隐瞒以下事实：羟碳酸镧新药申请的监管前景同样被夸大 [3] - 指控被告的公开陈述在相关时间均存在重大虚假和误导性 [3] 诉讼程序 - 在相关期间遭受损失的投资者需在2025年10月14日前请求法院指定其为首席原告 [4] - 作为集体诉讼成员可能有权获得补偿且无需支付任何自付费用 [4] 律所资质 - Levi & Korsinsky在过去20年中为受损股东追回数亿美元资金 [5] - 该律所拥有70多名员工组成的团队 连续七年被ISS证券集体诉讼服务评为美国顶级证券诉讼律所之一 [5]

诉讼案件基本情况 - 罗森律师事务所代表在2024年3月29日至2025年6月27日期间购买Unicycive Therapeutics Inc (NASDAQ: UNCY)证券的投资者提起集体诉讼 [1] - 投资者可通过应急费用安排获得补偿而无需支付任何自付费用 [2] - 投资者若希望担任首席原告需在2025年10月14日前向法院提出动议 [1][3] 诉讼指控内容 - 被告被指控在Unicycive满足FDA生产合规要求的能力方面存在虚假和/或误导性陈述 [5] - 被告被指控夸大了氧碳酸镧(OLC)新药申请(NDA)的监管前景 [5] - 这些虚假陈述导致投资者在市场了解真相后遭受损失 [5] 律师事务所背景 - 罗森律师事务所专注于证券集体诉讼和股东派生诉讼 [4] - 该所曾创下对中国公司最大证券集体诉讼和解记录 [4] - 2017年被ISS证券集体诉讼服务评为证券集体诉讼和解数量第一名 [4] - 自2013年以来每年排名前四 已为投资者追回数亿美元 [4] - 2019年单独为投资者获得超过4.38亿美元赔偿 [4]

NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Unicycive Therapeutics, Inc. investors who were adversely affected by alleged securities fraud between March 29, 2024 and June 27, 2025. Follow the link below to get more information and be contacted by a member of our team: ...